Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Advaxis, Inc.
(OB:
ADXS
)
0.0390
USD
-0.0001 (-0.26%)
Official Closing Price
/ Updated:
8:10 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
1,232,717
Open
0.0400
Bid (Size)
0.0500 (5200)
Ask (Size)
0.2400 (5000)
Prev. Close
0.0391
Today's Range
0.0390 - 0.0410
52wk Range
0.0275 - 0.1550
Shares Outstanding
595,867,092
Dividend Yield
N/A
Top News
More News
Advaxis Announces Voting Results of 2013 Annual Meeting of Stockholders
June 17, 2013
from
Business Wire News Releases
Advaxis Requests Orphan Drug Designation for Treatment of HPV-Associated Head and Neck Cancer with ADXS-HPV
June 11, 2013
from
Business Wire News Releases
More News
Read More
Advaxis Issues Letter Advising Stockholders to Vote FOR Proposals 2 and 3 of Proxy Statement
June 10, 2013
from
Business Wire News Releases
Advaxis Requests Orphan Drug Designation for Treatment of Cervical Cancer with ADXS-HPV
June 07, 2013
from
Business Wire News Releases
Zacks Research Issues Positive Marks for Advaxis (ADXS) Phase II Study for ADXS-HPV
June 07, 2013
from
Latest Press Releases
Advaxis Announces Withdrawal of Proxy Statement Proposal to Amend Its Incentive Plan at This Time
June 06, 2013
from
Business Wire News Releases
Advaxis Announces Amendment of Proxy Statement Supplement Further Reduction in Share Capital Proposal
June 04, 2013
from
Business Wire News Releases
Advaxis Reports Survival and New Analysis for ADXS-HPV in Patients with Recurrent Cervical Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
June 02, 2013
from
Business Wire News Releases
Advaxis Announces Filing of Proxy Statement Supplement and New Annual Meeting Date
May 23, 2013
from
Business Wire News Releases
The Guitammer Co (OTCBB:GTMM) And The Two Sides Of The Coin
May 20, 2013
category
Stocks
from
Hotstocked.com articles
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here